News

LAA occluder, Watchman

According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA) approval of Boston Scientific's Watchman device will drive rapid growth in the market for...

heart valve repair hybrid or cath lab reprise II boston scientific lotus tct

In a clinical trial of the Boston Scientific Lotus valve, a second-generation ...

hybrid approach to treating coronary artery disease that involves a hybrid procedure combining a minimally...

heart valve repair hybrid or cath lab structural heart tct medtronic corevalve

In a clinical trial, a self-expanding transcatheter aortic valve met the key performance objective of reducing...

cath lab tct advanced visualization hybrid or philips realview holographic 3-D

Philips and RealView Imaging Ltd. have completed a clinical study that demonstrated the feasibility of using an innovative live 3-D holographic ...

heart valve repair hybrid or cath lab

Boston Scientific Corp. has received CE mark for its Lotus Valve System, a transcatheter aortic valve replacement (TAVR) technology. This key approval offers an effective new...

trial study hybrid or heart valve repiar tct 2013 st. jude portico

St. Jude Medical Inc. announced positive results for the 23 and 25mm Portico Transcatheter Aortic Heart Valves in the Portico Transfemoral CE mark trial (Portico TF CE Trial)....

medtronic corevalve cath lab hybrid or heart valve repair study TCT 2013

The CoreValve U.S. pivotal trial showed very positive results for the Medtronic CoreValve system, comparable or better than data from the Sapien Partner Trial.

MitraClip, Abbott, transcatheter mitral valve repair, FDA approval

The U.S. Food and Drug Administration (FDA) has granted market clearance for the MitraClip, the first minimally invasive transcatheter device to repair mitral regurgitation (MR). The device is...

IMRIS siemens CT systems hybrid OR Visius iCT

IMRIS Inc. and Siemens Healthcare announced an agreement that positions one of Siemens’s computed tomography (CT)...

Eizo Corp. and Stryker Corp. announced their partnership to offer customers integrated large monitor management systems suitable for use in standard and hybrid operating rooms. As a...

Sapien, TAVR, hybrid OR

As a cutting-edge technique, many hospitals around the country are investigating the development of their own TAVR programs. Starting a TAVR program requires a collaborative commitment to care and...

Direct Flow Medical Inc. announced the first patient enrollment in the U.S. SALUS clinical trial. The trial will study the Direct Flow Medical Transcatheter Aortic Heart Valve System,...

IMRIS Inc. has obtained regulatory CE mark for Visius iCT, the first and only ceiling-mounted intraoperative computed tomography (CT)...

IMRIS has announced U.S. Food and Drug Administration (FDA) 510K clearance to market VISIUS iCT, the first and only ceiling-mounted ...

July 12, 2013 — A Chicago native living in southern California was the first patient at Scripps Health to receive a MitraClip as part of the clinical outcomes assessment of the MitraClip...

Researchers have announced the results of a clinical study that shows a key difference in the patient’s baseline heart size and function following transcatheter valve replacement (TAVR) that may...

Abbott has announced publication of positive outcomes from two European post-approval studies of the catheter-based MitraClip therapy for the treatment of mitral regurgitation (MR). Results...

Direct Flow Medical Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin the SALUS feasibility...

June 3, 2013 — Medtronic Inc. announced it has received CE mark for valve-in-valve (VIV) procedures using the CoreValve and CoreValve Evolut transcatheter aortic valve implantation (TAVI) systems...